Karolinska Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Survivin promotes a glycolytic switch in CD4+ T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis

    iScience, Vol. 25, Núm. 12